“Design, Molecular Docking, Synthesis, and Pharmacological Evaluation of Nabumetone-Derived Oxadiazole and Thiadiazole Schiff Bases As Potential EGFR Inhibitors for NSCLC”. Al Mustansiriyah Journal of Pharmaceutical Sciences, vol. 25, no. 5, Jan. 2026, pp. 973-91, https://doi.org/10.32947/ajps.v25i5.1318.